Gene Findings Unlocking Reasons for Neuroblastoma Risk
--Whole-Genome Searches Are Revealing Secrets of a Childhood Cancer--
PHILADELPHIA, June 22 /PRNewswire-USNewswire/ -- Two new studies from The Children's Hospital of Philadelphia advance the search for genetic events that result in neuroblastoma, a puzzling, often-deadly type of childhood ca...
Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
Published in June Issue of Circulation
SILVER SPRING, Md. and INDIANAPOLIS, June 9 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and Eli Lilly and Company (NYSE: LLY ) today announced the results of a pivotal 16-week study showing that a once-dail...
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
New Insights into the Prediction of IBD Using Serology Testing Also Presented
SAN DIEGO, June 2 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings
regarding a correlation between an important serologic marker used in the det...
Applying Clinical Findings to the Practice of Medicine
New research offers hope, propels treatment for common orthopaedic conditions
LAS VEGAS, Feb. 25 /PRNewswire-USNewswire/ -- The Kappa Delta Sorority and the Orthopaedic Research and Education Foundation (OREF) presented four research awards to scientists who are closing the gap between...
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide
Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides, issued the following statement on the results of the Phase II/IIb safety and effectiveness study of BufferGel and PRO2000 (0.5 percent concentration):
SILVER SPRING, Md., Feb. 9 /PRNewswire/ -- The Microbicide Trials N...
New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
BALTIMORE, Jan. 27 /PRNewswire/ -- Most Americans know their cholesterol level, but do they know how "sticky" their platelets are? Research findings
from Dr. Paul A. Gurbel, an interventional cardiologist and Director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimor...
Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows
Results reveal most respondents against expanding statin use broadly in wake of AHA-presented data
LITTLE FALLS, N.J., Nov. 25 /PRNewswire/ -- JUPITER, a clinical trial suggesting rosuvastatin may lower the cardiovascular risk of healthy patients with elevated CRP, should not prompt univ...
Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
Nearly 90 percent of patients achieve undetectable viral load in Phase
IIa trial within 28 days of combined treatment with standard of care
SAN FRANCISCO, Nov. 1 /PRNewswire/ -- New clinical data show antiviral
activity of TMC435, an investigational protease inhibitor (PI) being
Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress Findings
Confirm Potency of Poly-ICR as Vaccine Adjuvant
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals
Corporation (TSX: NVN) today presented positive data from preclinical
studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly
Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
SAN DIEGO, Oct. 7 /PRNewswire/ -- Prometheus Laboratories Inc., a
specialty pharmaceutical company, today announced findings
development of PROMETHEUS(R) IBS Diagnostic, the first and only blood test
for irritable bowel syndrome (IBS). The findings
differences in th...
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Data from SONIC Trial Showed REMICADE Therapy is More Likely to Induce Steroid-Free Remission and Mucosal Healing Compared with Standard Immunomodulator, Azathioprine
ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Data presented for the first time
from the Phase 3b Study of Patie...
More Findings on Gene Involved in Childhood Asthma
PHILADELPHIA, Sept. 15 /PRNewswire-USNewswire/ -- Asthma researchers
have found that a gene variant known to raise the risk of childhood asthma
in European children plays a similar role in white American children, but
not in African American children.
The most common chronic illness among ch...
Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
Genetic Variations Identify Predisposition to More Severe Knee Osteoarthritis
WALTHAM, Mass., Sept. 15 /PRNewswire-FirstCall/ -- Interleukin
Genetics, Inc. (Amex: ILI ), announced today that Kenneth Kornman, Ph.D.,
the company's Chief Scientific Officer, will ...
VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
Van Andel Institute researchers are first to associate unique DNA changes with several types of renal cell carcinoma
GRAND RAPIDS, Mich., Sept. 12 /PRNewswire/ -- Van Andel Institute (VAI)
researchers have identified unique DNA changes in each of several types of
renal cell carcin...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
- Systemic treatment with chemotherapy and pegylated enzyme produces significantly enhanced survival compared to chemotherapy alone - - Pegylated enzyme well tolerated -
SAN DIEGO, July 22 /PRNewswire-FirstCall/ -- Halozyme Therapeutics,
Inc. (Nasdaq: HALO ), a biopharma...
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
Data Provides Further Information on AVANDIA as a Safe and Effective Treatment Option for Appropriate Type 2 Diabetes Patients
PHILADELPHIA, July 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:
GSK) announces today that the U.S. Food and Drug Administration (FDA)
updated the prescr...
Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
Study Showing Results of Tengion Neo-Bladder Augment(TM) to be Featured in July Issue of the Journal of Urology
EAST NORRITON, Pa., June 12 /PRNewswire/ -- Tengion, Inc., a clinical
stage biotechnology company focused on the development of neo-organs and
neo-tissues, announced ...
Study Findings Show Infection Control Intervention Helps Keep Kids in School
Disinfecting and using hand sanitizers helped reduce absenteeism rates
in elementary schools
BOSTON, June 2 /PRNewswire-USNewswire/ -- A study from researchers at
Children's Hospital Boston published in Pediatrics found that a simple
infection control intervention in elementary schools -- dis...
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
BRIDGEWATER, N.J., May 15 /PRNewswire-FirstCall/ -- Sanofi-aventis
(EURONEXT: SAN and NYSE: SNY) announced today that findings
landmark ATHENA study showed Multaq(R) (dronedarone), a potential therapy
for the treatment of patients with atrial fibrillation or atrial flutter,
ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
Company Will Seek Label for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
IRVINE, Calif., April 30 /PRNewswire-FirstCall/ -- ISTA
Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced positive results from
the preliminary analysis of its second ...
ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
MEMPHIS, Tenn., April 21 /PRNewswire/ -- On Tuesday, April 15th, Lee S.
Schwartzberg, MD, FACP, President of the Accelerated Community Oncology
Research Network, Inc. presented findings
at the American Association for
Cancer Research annual meeting in San Diego. The Phase II study tested a
Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
- Data Support Intravenous to Subcutaneous Conversion -
SAN DIEGO, April 16 /PRNewswire-FirstCall/ -- Halozyme Therapeutics,
Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and
commercializing products targeting the extracellular matrix, today
announced new pre-clinical f...
Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
ROCHESTER, Minn., March 10 /PRNewswire-USNewswire/ -- Thousands of
research studies have documented how the oils known as omega-3 fatty acids
can benefit the cardiovascular system, particularly among people diagnosed
with coronary artery disease. The incredible volume of research on this
Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
RALEIGH, N.C., Dec. 13 /PRNewswire/ -- The most recent study from the
landmark Framingham trial demonstrates the clinical significance of knowing
the number of LDL particles (LDL-P) by NMR in the management of a patient's
risk for heart disease. This longitudinal outcomes study shows that low
Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
Results Show Statistically Significant Indications of PS433540's Potential in Treating Hypertension
PRINCETON, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq:
PCOP), an innovator in the discovery and development of novel small
molecule therapeutics, announced...
Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
Researchers share updates about sleep apnea and sleep behavior
ROCHESTER, Minn., Oct. 24 /PRNewswire-USNewswire/ -- Mayo Clinic
physicians offered updates about diagnosing and treating patients with a
variety of sleep disorders, including obstructive sleep apnea and sleep
Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoit's Brain
Neuropathological Tests Find Evidence of Chronic Traumatic Encephalopathy Consistent with Numerous Brain Injuries
NEW YORK, Sept. 5 /PRNewswire/ -- Leading medical experts associated
with the Sports Legacy Institute today appeared with Michael Benoit, father
of professional wrest...
Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
Unique Collaborative Meeting Includes Leading Scientists Investigating Pregnancy and Breast Cancer Prevention
HOUSTON, Nov. 15 /PRNewswire/ -- Eighteen scientists investigating
novel means for primary prevention of breast cancer by studying the natural
impact of pregnancy on b...
New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
Patients with Painful and Progressive Form of Inflammatory Spinal Arthritis Receiving Monthly Golimumab Treatment Showed Marked Improvements in Physical Function
BOSTON, Nov. 7 /PRNewswire/ -- More than half of patients receiving
monthly subcutaneous (SC) injections of...
Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at
the Fourth International Conference on Tumor Microenvironment in
- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN
AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Research
at Helix BioPharma Corp., a developer of novel cancer therapeutics,
will be presenting a scientific poster at the Fourth International
Conference on Tumor Microenvi...
DVT Awareness Survey Findings for Respondents in High-Risk Groups:
WASHINGTON, March 15, 2007 /PRNewswire/ -- Up to two million
Americans are affected each year by DVT, with up to 600,000
hospitalized. Its primary complication, pulmonary embolism (PE),
claims up to 300,000 lives annually -- more than breast cancer and
The Coalition to Prevent Dee...
Acuity One-Year Findings Meet All Primary Endpoints in Favor of
Angiomax (Bivalirudin) Alone Treatment Group
Major Bleeding in Patients Treated for Acute Coronary Syndromes
(ACS) Nearly Triples the Risk of Death at One Year
NEW ORLEANS, March 26, 2007 /PRNewswire/ -- One-year findings
from the landmark ACUITY trial show that acute coronary syndrome
(ACS) patients in the "Angiomax(R) (bivalirudin) alone" ...
Landmark Findings From ECLIPSE Program Show Improved Control of
Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Largest Randomized Safety Program of Intravenous Antihypertensives
to Date Presented at ACC Scientific Sessions
NEW ORLEANS, March 27, 2007 /PRNewswire-FirstCall/ -- Findings
from ECLIPSE**, the largest safety program comparing intravenous
antihypertensive therapies, show that improved control of
Pivotal Phase III Findings With Investigational Drug Cleviprex
(Clevidipine) Demonstrate Perioperative Blood Pressure Control In
First Presentation of Comparative Data from ECLIPSE, Largest Safety
Program of Intravenous Antihypertensive Agents
NEW ORLEANS, March 27, 2007 /PRNewswire-FirstCall/ -- Favorable
findings of the investigational drug Cleviprex(TM) (clevidipine)
compared to current intravenous antihypertensive agent...
Bionovo to Present Recent Findings of BZL101, Its Anti-cancer
Agent, at the American Association of Cancer Research
EMERYVILLE, Calif., April 16, 2007 /PRNewswire-FirstCall/ --
Bionovo, Inc. will present findings
on the mechanism of action of
its anti-cancer agent BZL101, which is advancing to Phase 1/2
clinical testing for late stage breast cancer at the American
Association of Cancer Research (AACR) being hel...
Abraxis BioScience Presents Pre-Clinical Findings That Support Role
of SPARC Expression in Cancer and the Role of the Nanoparticle
Albumin Bound (nab) Technology Platform in Targeting the Pathway
LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis BioScience,
Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical
company, announced results from two pre-clinical studies that
support the role of SPARC (secreted protein acidic and rich in
cysteine) expression in cancer and Abraxis' nanop...
Columbia Laboratories Reports Preliminary Findings from the Ongoing
Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%
(progesterone gel) to Prevent Preterm Birth
LIVINGSTON, N.J.--(BUSINESS WIRE)--Apr 26, 2007 - Columbia
Laboratories, Inc. (NASDAQ: CBRX) today announced that preliminary
results from the ongoing data analysis of the recently-completed
randomized, placebo-controlled, double-blind Phase III clinical
trial of PROCHIEVE(R) 8% (progesterone gel) ...
ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds
for Solid Tumors Are to be Reported at ASCO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen, Inc.
(Nasdaq: IMGN), a biopharmaceutical company that develops targeted
anticancer therapeutics using its Tumor-Activated Prodrug (TAP)
technology, today announced that clinical findings
different TAP compounds for the treatment...
Prana Biotechnology Presents New Key Findings on PBT2
PBT2 Alters Biomarkers and Rapidly Improves Cognition in two
distinct models of Alzheimer's Disease
MELBOURNE, Australia - June 7, 2007 - Prana Biotechnology
Limited (NASDAQ: PRAN / ASX: PBT), a biopharmaceutical company
focused on the research and development of treatments for
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune
THE WOODLANDS, Texas, June 08, 2007 /PRNewswire-FirstCall/ --
Lexicon Pharmaceuticals, Inc. today announced the publication of
from a joint research project with scientists at Fox
Chase Cancer Center in Philadelphia, PA. Together with David L.
Wiest, Ph.D., Lexicon researchers have di...